Biomolecules at Kenyon  HHMI at Kenyon  Jmol Home  Biology Dept  COMMENTS and CORRECTIONS

Phenylalanine-4-hydroxylase

Iris Pardue '24 and Safia Mohan '24


Contents:


I. Introduction

The gene PAH encodes the enzyme phenylalanine-4-hydroxylase, a protein responsible for the conversion of phenylalanine to tyrosine. It plays an important role in the metabolism of amino acids throughout the body. It is a member of the family of amino acid hydroxylases, and shares several structural and functional motifs. 

Mutations in this enzyme result in phenylketonuria or PKU, an autosomal recessive genetic condition that reduces the ability of the affected individual to metabolize phenylalanine. The disease can either manifest in its classical form where the activity of the enzyme itself is affected; or in variant PKU, where enzyme function is not directly impeded but the a change in the presence of its cofactors reduces its efficiency. The classical form is incurable but can be treated with low-phenylalanine diets, while the variant form can sometimes be treated with supplements of the necessary cofactors.


II. General Structure

Phenylalanine-4-hydroxylase is a 77.4 kDa tetramer composed of two identical dimers . Each monomer has its own tetrameric and catalytic domains. The tetrameric domain is where all 4 monomers interact to form the tetramer. The catalytic domain is composed of the rest of the compund, it is the reigon that binds Fe and interacts with phyenylalanine. 


III. Catalyst Binding

The Fe ion binds HIS285, HIS290, and GLU330 in order to properly coordinate it to the correct position. It rests in close proximity to BH4 (tetrahydrobiopterin), a molecule that acts as a necessary catalyst for hydroxylation along with enzyme stabilization, but interestingly slows enzyme folding into the active conformation. BH4 is stabilized by H-bond interactions with S23, G247, L249, S251, and Y377; along with pi-stacking interactions with F254.

Notably,E286 is involved in bonding with both catalytic molecules through interactions with water.


IV. Metabolite Binding

Phenylalanine-4-hydroxylase is catalyzed by Fe(II) ion and BH4. The hydroxylation is thought to proceed via a Fe(IV)=O intermediate formed from the Fe(II) ion and free O2, oxidizing the BH4 in the process. This Fe(IV) species then goes on to attack the phenyl ring of the phenylalanine, disrupting its aromaticity to form an Fe-O-phenyl bridge. This decomposes and releases the Fe ion to form an O=phenyl bond, which tautomerizes to HO-phenyl to restore the aromaticity and form the end product of tyrosine.


V. Mutated Regions

Mutations in the enzyme are well studied and important to characterizing the pathology of PKU, and many revolve around binding of the catalytic molecules described above. For example, the mutation of F254 to alanine resulted in a significant decrease in the affinity of the enzyme for BH4, and mutation of the same position to leucine extremely hindered the ability of the enzyme to bind substrate phenylalanine. Mutations in E286 to either alanine or glutamine both significantly decreased reaction rate as well, likely due to its importance in coordinating binding of both catalysts. Understanding these mutations and interactions allows us to better treat PKU cases by understanding how and when supplementation with synthetic analogs of BH4 can restore enzyme function, and when that treatment may be ineffective.



VI. References

  Fabrizia Fusetti, Heidi Erlandsen, Torgeir Flatmark, and Raymond C. Stevens. 1998. Structure of Tetrameric Human Phenylalanine Hydroxylase and Its Implications for Phenylketonuria. The Journal of Biological Chemistry 273: 16962-16967

Marte Innselset Flydal, Martin Alcoro-Pages, Fredrik Gullaksen Johannessen, Siseth Martinez-Caballerp, Lars Skjaerven, Rafael Fernandez-Leiro, Aurora Martinez, and Juan A. Hermoso. 2019. Structure of full-length human phenylalanine hydroxylase in complex with tetrahydrobiopterin. Proceedings of the National Academy of Sciences 116: 11229-111234.

Heidi Erlandsen, Elisa Bjorgo, Torgeir Flatmark, and Raymond C. Stevens. 2000. Crystal Structure and Site-Specific Mutagenesis of Pterin-Bound Human Phenylalanine Hydroxylase. Biochemistry 39: 2208-2217.

Fitzpatrick, P. F. (2003). Mechanism of Aromatic Amino Acid Hydroxylation. Biochemistry, 42(48), 14083–14091. https://doi.org/10.1021/bi035656u

Back to Top